GlobeNewswire: Researchmoz Global Pvt Ltd Contains the last 10 of 251 releaseshttp://www.globenewswire.com/External?Length=42024-03-29T08:13:41ZGlobeNewswirehttp://www.globenewswire.com/External?Length=4newsdesk@globenewswire.com (NewsDesk)https://www.globenewswire.com/news-release/2016/09/22/873868/0/en/Global-Biofuels-Market-Will-Grow-Steadily-At-A-CAGR-Of-5-87-During-The-Period-2016-2020-ResearchMoz.html?f=22&fvtc=4&fvtv=27458Global Biofuels Market Will Grow Steadily At A CAGR Of 5.87% During The Period 2016-2020: ResearchMoz2016-09-22T12:30:00Z<![CDATA[ResearchMoz.us has announced a new research study titled ‘Global Bio-fuels Market 2016-2020’ to its vast repository of market intelligence reports. ResearchMoz.us has announced a new research study titled ‘Global Bio-fuels Market 2016-2020’ to its vast repository of market intelligence reports. ]]>https://www.globenewswire.com/news-release/2016/09/20/873157/0/en/Global-Cloud-Computing-Market-in-Higher-Education-Will-Grow-Steadily-At-a-CAGR-of-24-57-during-the-Period-2016-2020-ResearchMoz.html?f=22&fvtc=4&fvtv=27458Global Cloud Computing Market in Higher Education Will Grow Steadily At a CAGR of 24.57% during the Period 2016-2020: ResearchMoz2016-09-20T12:31:53Z<![CDATA[ResearchMoz.us has announced a new research study titled ‘Global Cloud Computing Market in Higher Education 2016-2020’ to its vast repository of market intelligence reports. ResearchMoz.us has announced a new research study titled ‘Global Cloud Computing Market in Higher Education 2016-2020’ to its vast repository of market intelligence reports.]]>https://www.globenewswire.com/news-release/2016/09/16/872477/0/en/The-Respiratory-Disorders-Market-is-forecast-to-rise-from-a-value-of-28-1-billion-in-2015-to-46-6-billion-in-2022-at-a-CAGR-of-7-5-ResearchMoz.html?f=22&fvtc=4&fvtv=27458The Respiratory Disorders Market is forecast to rise from a value of $28.1 billion in 2015 to $46.6 billion in 2022, at a CAGR of 7.5%: ResearchMoz2016-09-16T13:18:08Z<![CDATA[ResearchMoz.us has announced a new research study titled ‘Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way’ to its vast repository of market intelligence reports. ResearchMoz.us has announced a new research study titled ‘Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way’ to its vast repository of market intelligence reports. ]]>https://www.globenewswire.com/news-release/2016/09/16/872430/0/en/Frontier-Pharma-Chronic-Acute-and-Neuropathic-Pain-GPCR-and-Nerve-Growth-Factor-based-therapies-offer-strong-potential-in-difficult-to-treat-subtypes-ResearchMoz.html?f=22&fvtc=4&fvtv=27458Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes: ResearchMoz2016-09-16T11:05:07Z<![CDATA[ResearchMoz.us has announced a new research study titled ‘Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes’ to its vast repository of market intelligence reports. ResearchMoz.us has announced a new research study titled ‘Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes’ to its vast repository of market intelligence reports. ]]>https://www.globenewswire.com/news-release/2016/09/15/872130/0/en/The-Respiratory-Disorders-Market-is-forecast-to-rise-from-a-value-of-28-1-billion-in-2015-to-46-6-billion-in-2022-at-a-CAGR-of-7-5-ResearchMoz.html?f=22&fvtc=4&fvtv=27458The Respiratory Disorders Market is forecast to rise from a value of $28.1 billion in 2015 to $46.6 billion in 2022, at a CAGR of 7.5%: ResearchMoz2016-09-15T12:34:05Z<![CDATA[ResearchMoz.us has announced a new research study titled ‘Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way’ to its vast repository of market intelligence reports ResearchMoz.us has announced a new research study titled ‘Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way’ to its vast repository of market intelligence reports]]>https://www.globenewswire.com/news-release/2016/09/14/871834/0/en/Frontier-Pharma-Chronic-Acute-and-Neuropathic-Pain-GPCR-and-Nerve-Growth-Factor-based-therapies-offer-strong-potential-in-difficult-to-treat-subtypes-ResearchMoz.html?f=22&fvtc=4&fvtv=27458Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes: ResearchMoz2016-09-14T13:03:16Z<![CDATA[ResearchMoz.us has announced a new research study titled ‘Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes’ to its vast repository of market intelligence reports. ResearchMoz.us has announced a new research study titled ‘Frontier Pharma: Chronic, Acute and Neuropathic Pain - GPCR and Nerve Growth Factor-based therapies offer strong potential in difficult-to-treat subtypes’ to its vast repository of market intelligence reports. ]]>https://www.globenewswire.com/news-release/2016/09/12/871160/0/en/Global-Touchless-Sensing-Equipment-Market-Will-Grow-At-A-CAGR-of-10-22-during-2016-2020-ResearchMoz.html?f=22&fvtc=4&fvtv=27458Global Touchless Sensing Equipment Market Will Grow At A CAGR of 10.22% during 2016-2020: ResearchMoz2016-09-12T13:18:20Z<![CDATA[ResearchMoz.us has announced a new research study titled ‘Global Touchless Sensing Equipment Market 2016-2020’ to its vast repository of market intelligence reports. ResearchMoz.us has announced a new research study titled ‘Global Touchless Sensing Equipment Market 2016-2020’ to its vast repository of market intelligence reports. ]]>https://www.globenewswire.com/news-release/2016/09/08/870403/0/en/Opportunities-and-Challenges-in-NFV-SDN-Wireless-Network-Infrastructure-Market-over-Forecast-2016-2030.html?f=22&fvtc=4&fvtv=27458Opportunities and Challenges in NFV, SDN & Wireless Network Infrastructure Market over Forecast 2016 - 20302016-09-08T09:42:38Z<![CDATA[Albany - NY: Researchmoz has released a new market report titled “The NFV, SDN & Wireless Network Infrastructure Market: 2016 - 2030 - Opportunities, Challenges, Strategies and Forecasts”. Service providers continue to face increasing CapEx and OpEx burdens, amid growing requirements for high-speed mobile broadband services. By eliminating reliance on expensive proprietary hardware platforms, NFV (Network Functions Virtualization) and SDN (Software Defined Networking) promise to reduce service provider CapEx. In addition, both technologies can significantly slash OpEx due to a reduction in physical space, labor and power consumption. Albany - NY: Researchmoz has released a new market report titled “The NFV, SDN & Wireless Network Infrastructure Market: 2016 - 2030 - Opportunities, Challenges, Strategies and Forecasts”. Service providers continue to face increasing CapEx and OpEx burdens, amid growing requirements for high-speed mobile broadband services. By eliminating reliance on expensive proprietary hardware platforms, NFV (Network Functions Virtualization) and SDN (Software Defined Networking) promise to reduce service provider CapEx. In addition, both technologies can significantly slash OpEx due to a reduction in physical space, labor and power consumption.]]>https://www.globenewswire.com/news-release/2016/09/07/870087/0/en/Global-Diabetes-and-Obesity-Drugs-Market-to-reach-163-2-Billion-by-2022-Insulins-and-GPCRs-Retain-Commercial-Prominence-While-High-Unmet-Need-Remains-in-Weight-Loss-Treatment-Resea.html?f=22&fvtc=4&fvtv=27458Global Diabetes and Obesity Drugs Market to reach $163.2 Billion by 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment: ResearchMoz2016-09-07T12:00:00Z<![CDATA[ResearchMoz.us has announced a new research study on ‘Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment’ to its vast repository of market intelligence reports. ResearchMoz.us has announced a new research study on ‘Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment’ to its vast repository of market intelligence reports.]]>https://www.globenewswire.com/news-release/2016/09/07/870000/0/en/The-5G-Wireless-Ecosystem-2016-2030-Technologies-Applications-Verticals-Strategies-Forecasts-ResearchMoz.html?f=22&fvtc=4&fvtv=27458The 5G Wireless Ecosystem 2016-2030 - Technologies, Applications, Verticals, Strategies & Forecasts: ResearchMoz2016-09-07T09:30:00Z<![CDATA[ResearchMoz.us has announced a new research study on ‘Market Future and Opportunities of the 5G Wireless Ecosystemover Forecast period 2016-2030’ to its vast repository of market intelligence reports. ResearchMoz.us has announced a new research study on ‘Market Future and Opportunities of the 5G Wireless Ecosystemover Forecast period 2016-2030’ to its vast repository of market intelligence reports.]]>